Hrt Financial LP Enochian Biosciences Inc Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.3 - $4.7 $61,180 - $66,871	14,228 New	14,228 $45,000
Q1 2023 May 12, 2023	BUY	$0.91 - $1.31 $35,227 - $50,712	38,712 New	38,712 $35,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $187,224 - $323,537	-41,058 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $122,239 - $282,314	-41,578 Reduced 50.31%	41,058 $204,000
Q1 2021 May 17, 2021	BUY	$3.02 - $4.51 $249,560 - $372,688	82,636 New	82,636 $292,000
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $118,485 - $149,156	-42,016 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.42 - $4.55 $143,694 - $191,172	42,016 New	42,016 $150,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.